US 9255076
Arylpiperazine derivatives and methods of utilizing same
granted A61KA61K31/538A61P
Quick answer
US patent 9255076 (Arylpiperazine derivatives and methods of utilizing same) held by REVIVA PHARMACEUTICALS, INC. expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/538, A61P, A61P25/00, A61P25/18